EMUGEN

Owner

Goods & Services

Pharmaceutical and biological preparations, namely, gene therapy products for the treatment of Rett Syndrome, Dravet Syndrome, neurological diseases and disorders, central nervous system disease and disorders, and genetic diseases and disorders; Pharmaceutical preparations for gene replacement and gene regulation in diseases, disorders, and conditions affecting the brain and central nervous system; Drug delivery agents, namely, bioengineered adeno-associated virus vectors for delivering gene therapies across blood-brain barrier

Scientific research and development of new technologies and products in the field of gene therapy, neurology, neurobiology, and genetic medicine; Bioengineering of adeno-associated virus vectors for use in gene therapy, and other gene regulation and gene replacement technologies; Providing scientific research information in the field of gene therapy, neurology, neurobiology, genetic medicine, and drug delivery across blood-brain barrier